{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T22:54:35Z","timestamp":1794869675232,"version":"4.9.1"},"reference-count":46,"publisher":"American Society of Hematology","issue":"21","license":[{"start":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T00:00:00Z","timestamp":1725408000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,11,12]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Bleeding disorder of unknown cause (BDUC) is a diagnosis of exclusion after evaluation of plasma coagulation and platelet function. Patients with BDUC (n\u00a0=\u00a0375) recorded in the Vienna Bleeding Biobank were analyzed in comparison with healthy controls (HCs; n\u00a0=\u00a0100) in this case-control study. Plasmin generation (PG) parameters were analyzed using calibrated fluorescence detection in citrated plasma. Turbidimetric plasma clot formation\/lysis of 293 (78%) patients with BDUC and confocal microscopy of clots from representative patients with BDUC (n\u00a0=\u00a06) and HCs (n\u00a0=\u00a09) were assessed. In the PG analysis, patients with BDUC exhibited lower velocity and peak plasmin levels but a higher endogenous plasmin potential than HCs. Peak plasmin levels correlated with maximum clot absorbance but not with clot lysis time. Clot absorbance is an indicator of clot fiber density. Confocal microscopy analysis revealed a tendency towards thicker fibers in clots of patients with BDUC, which negatively correlated with peak plasmin (r\u00a0=\u00a0\u22120.561; P\u00a0=\u00a0.030). Peak plasmin correlated weakly with factor XIII, but not with other fibrinolytic factors (alpha2-antiplasmin, thrombin activatable fibrinolysis inhibitor, or plasminogen activator inhibitor 1) or bleeding severity. A model comprising fibrinogen and parameters of PG yielded high predictive power in discriminating between patients with BDUC and HCs across a fivefold stratified cross validation (80% of data; mean area under the curve [AUC], 0.847). The model generalized well to unseen data (20% of data; AUC, 0.856). Overall, patients with BDUC counterintuitively exhibited reduced peak plasmin levels, potentially related to altered clot structure.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/bloodadvances.2024012855","type":"journal-article","created":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T15:15:21Z","timestamp":1725462921000},"page":"5663-5673","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":14,"title":["Plasmin generation analysis in patients with bleeding disorder of unknown cause"],"prefix":"10.1182","volume":"8","author":[{"given":"Dino","family":"Mehic","sequence":"first","affiliation":[{"name":"1Division of Hematology and Hemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7058-5038","authenticated-orcid":false,"given":"St\u00e9phanie E.","family":"Reitsma","sequence":"additional","affiliation":[{"name":"2Department of Pathology and Laboratory Medicine, UNC Blood Research Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1142-0978","authenticated-orcid":false,"given":"Claire","family":"de Moreuil","sequence":"additional","affiliation":[{"name":"1Division of Hematology and Hemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, Austria"},{"name":"3UMR 1304, GETBO, Universit\u00e9 de Bretagne Occidentale, Brest, France"},{"name":"4Internal Medicine, Vascular Medicine and Pneumology Department, Brest University Hospital, Brest, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4605-2503","authenticated-orcid":false,"given":"Helmuth","family":"Haslacher","sequence":"additional","affiliation":[{"name":"5Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9699-3390","authenticated-orcid":false,"given":"Maximilian C.","family":"Koeller","sequence":"additional","affiliation":[{"name":"6Department of Pathology, Medical University of Vienna, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9596-1944","authenticated-orcid":false,"given":"Bas","family":"de Laat","sequence":"additional","affiliation":[{"name":"7Department of Biochemistry, Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, The Netherlands"},{"name":"8Synapse Research Institute, Maastricht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2607-9717","authenticated-orcid":false,"given":"Cihan","family":"Ay","sequence":"additional","affiliation":[{"name":"1Division of Hematology and Hemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Pabinger","sequence":"additional","affiliation":[{"name":"1Division of Hematology and Hemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alisa S.","family":"Wolberg","sequence":"additional","affiliation":[{"name":"2Department of Pathology and Laboratory Medicine, UNC Blood Research Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4578-3120","authenticated-orcid":false,"given":"Johanna","family":"Gebhart","sequence":"additional","affiliation":[{"name":"1Division of Hematology and Hemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2024,10,31]]},"reference":[{"issue":"19","key":"2024111214154166400_bib1","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1182\/blood.2020010038","article-title":"How I treat bleeding disorder of unknown cause","volume":"138","author":"Baker","year":"2021","journal-title":"Blood"},{"issue":"7","key":"2024111214154166400_bib2","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/j.jtha.2024.03.005","article-title":"Standardization of definition and management for bleeding disorder of unknown cause: communication from the SSC of the ISTH","volume":"22","author":"Baker","year":"2024","journal-title":"J Thromb Haemostasis"},{"issue":"7","key":"2024111214154166400_bib3","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/j.jtha.2023.03.006","article-title":"Risk factors for future bleeding in patients with mild bleeding disorders: longitudinal data from the Vienna Bleeding Biobank","volume":"21","author":"Mehic","year":"2023","journal-title":"J Thromb Haemostasis"},{"issue":"3","key":"2024111214154166400_bib4","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/hae.13422","article-title":"High proportion of patients with bleeding of unknown cause in persons with a mild-to-moderate bleeding tendency: results from the Vienna Bleeding Biobank (VIBB)","volume":"24","author":"Gebhart","year":"2018","journal-title":"Haemophilia"},{"key":"2024111214154166400_bib5","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ejim.2020.04.023","article-title":"The discriminatory power of bleeding assessment tools in adult patients with a mild to moderate bleeding tendency","volume":"78","author":"Gebhart","year":"2020","journal-title":"Eur J Intern Med"},{"issue":"9","key":"2024111214154166400_bib6","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1111\/jth.14529","article-title":"Thrombin-generating potential, plasma clot formation, and clot lysis are impaired in patients with bleeding of unknown cause","volume":"17","author":"Hofer","year":"2019","journal-title":"J\u00a0Thromb Haemost"},{"issue":"3","key":"2024111214154166400_bib7","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s00277-016-2893-6","article-title":"Fibrinolysis in patients with a mild-to-moderate bleeding tendency of unknown cause","volume":"96","author":"Gebhart","year":"2017","journal-title":"Ann Hematol"},{"issue":"2","key":"2024111214154166400_bib8","doi-asserted-by":"crossref","first-page":"e12681","DOI":"10.1002\/rth2.12681","article-title":"Fibrinolytic assays in bleeding of unknown cause: improvement in diagnostic yield","volume":"6","author":"Valke","year":"2022","journal-title":"Res Pract Thromb Haemost"},{"issue":"8","key":"2024111214154166400_bib9","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1111\/jth.14160","article-title":"Hemorrhagic disorders of fibrinolysis: a clinical review","volume":"16","author":"Saes","year":"2018","journal-title":"J\u00a0Thromb Haemost"},{"issue":"4","key":"2024111214154166400_bib10","doi-asserted-by":"crossref","first-page":"e12511","DOI":"10.1002\/rth2.12511","article-title":"Fibrinolysis and bleeding of unknown cause","volume":"5","author":"Mehic","year":"2021","journal-title":"Res Pract Thromb Haemost"},{"issue":"4","key":"2024111214154166400_bib11","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/jth.13957","article-title":"Measuring fibrinolysis: from research to routine diagnostic assays","volume":"16","author":"Longstaff","year":"2018","journal-title":"J\u00a0Thromb Haemost"},{"issue":"5","key":"2024111214154166400_bib12","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.3390\/ijms22052758","article-title":"Assessing plasmin generation in health and disease","volume":"22","author":"Miszta","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"19","key":"2024111214154166400_bib13","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1182\/blood.2019004267","article-title":"A\u00a0high-fat diet delays plasmin generation in a thrombomodulin-dependent manner in mice","volume":"135","author":"Miszta","year":"2020","journal-title":"Blood"},{"issue":"1","key":"2024111214154166400_bib14","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/jth.15114","article-title":"Application of a plasmin generation assay to define pharmacodynamic effects of tranexamic acid in women undergoing cesarean delivery","volume":"19","author":"Miszta","year":"2021","journal-title":"J\u00a0Thromb Haemost"},{"issue":"9","key":"2024111214154166400_bib15","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1111\/jth.12645","article-title":"No increased systemic fibrinolysis in women with heavy menstrual bleeding","volume":"12","author":"Wiewel-Verschueren","year":"2014","journal-title":"J\u00a0Thromb Haemost"},{"issue":"1-2","key":"2024111214154166400_bib16","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.cca.2008.11.006","article-title":"Procarboxypeptidase U (TAFI) and the Thr325Ile proCPU polymorphism in patients with hereditary mucocutaneous hemorrhages","volume":"401","author":"Matus","year":"2009","journal-title":"Clin Chim Acta"},{"issue":"1","key":"2024111214154166400_bib17","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1538-7836.2005.01709.x","article-title":"Evaluation of low PAI-1 activity as a risk factor for hemorrhagic diathesis","volume":"4","author":"Agren","year":"2006","journal-title":"J\u00a0Thromb Haemost"},{"issue":"1","key":"2024111214154166400_bib18","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1471-2253-12-27","article-title":"PAI-1 and t-PA\/PAI-1 complex potential markers of fibrinolytic bleeding after cardiac surgery employing cardiopulmonary bypass","volume":"12","author":"Ozolina","year":"2012","journal-title":"BMC Anesthesiol"},{"issue":"6","key":"2024111214154166400_bib19","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1046\/j.1365-2516.2002.00686.x","article-title":"Paradoxical hyperfibrinolysis is associated with a more intensely haemorrhagic phenotype in severe congenital haemophilia","volume":"8","author":"Gr\u00fcnewald","year":"2002","journal-title":"Haemophilia"},{"issue":"4","key":"2024111214154166400_bib20","doi-asserted-by":"crossref","first-page":"e0125069","DOI":"10.1371\/journal.pone.0125069","article-title":"Increased plasma clot permeability and susceptibility to lysis are associated with heavy menstrual bleeding of unknown cause: a case-control study","volume":"10","author":"Szczepaniak","year":"2015","journal-title":"PLoS One"},{"issue":"4","key":"2024111214154166400_bib21","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1111\/j.1365-2516.2012.02759.x","article-title":"Retrospective evaluation of bleeding tendency and simultaneous thrombin and plasmin generation in patients with rare bleeding disorders","volume":"18","author":"Van Geffen","year":"2012","journal-title":"Haemophilia"},{"issue":"6","key":"2024111214154166400_bib22","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1089\/bio.2018.0032","article-title":"Usage data and scientific impact of the prospectively established fluid bioresources at the hospital-based MedUni Wien Biobank","volume":"16","author":"Haslacher","year":"2018","journal-title":"Biopreserv Biobank"},{"issue":"12","key":"2024111214154166400_bib23","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1111\/j.1538-7836.2005.01663.x","article-title":"The discriminant power of bleeding history for the diagnosis of type 1 von Willebrand disease: an international, multicenter study","volume":"3","author":"Rodeghiero","year":"2005","journal-title":"J\u00a0Thromb Haemost"},{"issue":"9","key":"2024111214154166400_bib24","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1111\/j.1538-7836.2010.03975.x","article-title":"ISTH\/SSC bleeding assessment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders","volume":"8","author":"Rodeghiero","year":"2010","journal-title":"J\u00a0Thromb Haemost"},{"issue":"5","key":"2024111214154166400_bib25","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/j.1365-2141.2005.05820.x","article-title":"High dose factor VIIa improves clot structure and stability in a model of haemophilia B","volume":"131","author":"Wolberg","year":"2005","journal-title":"Br J Haematol"},{"issue":"6","key":"2024111214154166400_bib26","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.thromres.2011.04.009","article-title":"Recombinant factor VIIa analog NN1731 (V158D\/E296V\/M298Q-FVIIa) enhances fibrin formation, structure and stability in lipidated hemophilic plasma","volume":"128","author":"Gray","year":"2011","journal-title":"Thromb Res"},{"issue":"6","key":"2024111214154166400_bib27","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1111\/hae.14433","article-title":"Thrombomodulin in patients with mild to moderate bleeding tendency","volume":"27","author":"Mehic","year":"2021","journal-title":"Haemophilia"},{"issue":"14","key":"2024111214154166400_bib28","doi-asserted-by":"crossref","first-page":"4231","DOI":"10.3390\/jcm13144231","article-title":"Predelivery haemostatic biomarkers in women with non-severe postpartum haemorrhage","volume":"13","author":"De Moreuil","year":"2024","journal-title":"JCM"},{"issue":"3","key":"2024111214154166400_bib29","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.blre.2006.11.001","article-title":"Thrombin generation and fibrin clot structure","volume":"21","author":"Wolberg","year":"2007","journal-title":"Blood Rev"},{"issue":"2","key":"2024111214154166400_bib30","doi-asserted-by":"crossref","first-page":"100081","DOI":"10.1016\/j.rpth.2023.100081","article-title":"Fibrinolysis: an illustrated review","volume":"7","author":"Risman","year":"2023","journal-title":"Res Pract Thromb Haemost"},{"issue":"5","key":"2024111214154166400_bib31","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/hae.14356","article-title":"Natural anticoagulants: a missing link in mild to moderate bleeding tendencies","volume":"27","author":"Mehic","year":"2021","journal-title":"Haemophilia"},{"issue":"12","key":"2024111214154166400_bib32","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.1111\/jth.15106","article-title":"Pharmacodynamic monitoring of factor VIII replacement therapy in hemophilia A: combining thrombin and plasmin generation","volume":"18","author":"Valke","year":"2020","journal-title":"J\u00a0Thromb Haemost"},{"issue":"4","key":"2024111214154166400_bib33","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1160\/TH13-04-0345","article-title":"Simultaneous measurement of thrombin and plasmin generation to assess the interplay between coagulation and fibrinolysis","volume":"110","author":"Matsumoto","year":"2013","journal-title":"Thromb Haemost"},{"issue":"6","key":"2024111214154166400_bib34","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1111\/hae.13842","article-title":"Thrombin and plasmin generation in patients with plasminogen or plasminogen activator inhibitor type 1 deficiency","volume":"25","author":"Saes","year":"2019","journal-title":"Haemophilia"},{"issue":"11","key":"2024111214154166400_bib35","doi-asserted-by":"crossref","first-page":"2896","DOI":"10.1111\/jth.15524","article-title":"Thrombin generation measured by two platforms in patients with a bleeding tendency: Comment","volume":"19","author":"Thomas","year":"2021","journal-title":"J\u00a0Thromb Haemost"},{"issue":"1","key":"2024111214154166400_bib36","doi-asserted-by":"crossref","first-page":"044","DOI":"10.1055\/s-0039-1698460","article-title":"Interpretation and validation of maximum absorbance data obtained from turbidimetry analysis of plasma clots","volume":"120","author":"Pieters","year":"2020","journal-title":"Thromb Haemost"},{"issue":"2","key":"2024111214154166400_bib37","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1182\/blood-2010-06-290338","article-title":"The interplay between tissue plasminogen activator domains and fibrin structures in the regulation of fibrinolysis: kinetic and microscopic studies","volume":"117","author":"Longstaff","year":"2011","journal-title":"Blood"},{"issue":"5","key":"2024111214154166400_bib38","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1161\/01.ATV.20.5.1354","article-title":"Influence of fibrin network conformation and fibrin fiber diameter on fibrinolysis speed: dynamic and structural approaches by confocal microscopy","volume":"20","author":"Collet","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"24","key":"2024111214154166400_bib39","doi-asserted-by":"crossref","first-page":"21331","DOI":"10.1074\/jbc.M212734200","article-title":"Dynamic changes of fibrin architecture during fibrin formation and intrinsic fibrinolysis of fibrin-rich clots","volume":"278","author":"Collet","year":"2003","journal-title":"J\u00a0Biol Chem"},{"issue":"8","key":"2024111214154166400_bib40","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1182\/blood.V82.8.2462.2462","article-title":"Dusart syndrome: a new concept of the relationship between fibrin clot architecture and fibrin clot degradability: hypofibrinolysis related to an abnormal clot structure","volume":"82","author":"Collet","year":"1993","journal-title":"Blood"},{"issue":"suppl 1","key":"2024111214154166400_bib41","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1538-7836.2007.02504.x","article-title":"Structure of fibrin: impact on clot stability","volume":"5","author":"Weisel","year":"2007","journal-title":"J\u00a0Thromb Haemost"},{"issue":"5","key":"2024111214154166400_bib42","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/0049-3848(94)90227-5","article-title":"Fibrin in human plasma: gel architectures governed by rate and nature of fibrinogen activation","volume":"75","author":"Blomback","year":"1994","journal-title":"Thromb Res"},{"issue":"5","key":"2024111214154166400_bib43","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1097\/00001721-199410000-00007","article-title":"Changes in clot deformability--a possible explanation for the epidemiological association between plasma fibrinogen concentration and myocardial infarction","volume":"5","author":"Scrutton","year":"1994","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"9","key":"2024111214154166400_bib44","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1161\/01.ATV.0000136649.83297.bf","article-title":"Genetic and environmental determinants of fibrin structure and function: relevance to clinical disease","volume":"24","author":"Scott","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"7","key":"2024111214154166400_bib45","doi-asserted-by":"crossref","first-page":"3670","DOI":"10.3390\/ijms22073670","article-title":"Thrombin activatable fibrinolysis inhibitor (TAFI): an updated narrative review","volume":"22","author":"Sillen","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"8","key":"2024111214154166400_bib46","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1161\/ATVBAHA.122.317164","article-title":"Fibrinogen and factor XIII in venous thrombosis and thrombus stability","volume":"42","author":"Wolberg","year":"2022","journal-title":"ATVB"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/8\/21\/5663\/2312502\/blooda_adv-2024-012855-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/8\/21\/5663\/2312502\/blooda_adv-2024-012855-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T09:16:36Z","timestamp":1731402996000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/8\/21\/5663\/517661\/Plasmin-generation-analysis-in-patients-with"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,31]]},"references-count":46,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2024,11,12]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2024012855","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,31]]}}}